ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

October 25, 2013

Award Fees Show House NCI thinks FCRF Contractors Are Performing

August 15, 1986

In Brief: Brian Henderson Names New Director Of USC Comprehensible Cancer Center, Norris Hospital

April 8, 1983

NCI to release RFP for Cancer Information Service recompetition.

November 28, 2003

Eye Institute Director Kupfer Steps Down; UICC Begins Web-Based Surgical Pathology.

July 7, 2000

In Brief: Lombardi Comprehensive Designation Renewed; Yale Plans Breast Cancer Lab

September 26, 1997